[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69509544D1 - Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten - Google Patents

Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Info

Publication number
DE69509544D1
DE69509544D1 DE69509544T DE69509544T DE69509544D1 DE 69509544 D1 DE69509544 D1 DE 69509544D1 DE 69509544 T DE69509544 T DE 69509544T DE 69509544 T DE69509544 T DE 69509544T DE 69509544 D1 DE69509544 D1 DE 69509544D1
Authority
DE
Germany
Prior art keywords
ostrogen
ovarial
treatment
composition
dependent diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69509544T
Other languages
English (en)
Other versions
DE69509544T2 (de
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDICAL COLLEGE OF HAMPTON ROADS NORFOLK VA US
Medical College of Hampton Roads
Original Assignee
MEDICAL COLLEGE OF HAMPTON ROADS NORFOLK VA US
Medical College of Hampton Roads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDICAL COLLEGE OF HAMPTON ROADS NORFOLK VA US, Medical College of Hampton Roads filed Critical MEDICAL COLLEGE OF HAMPTON ROADS NORFOLK VA US
Publication of DE69509544D1 publication Critical patent/DE69509544D1/de
Application granted granted Critical
Publication of DE69509544T2 publication Critical patent/DE69509544T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69509544T 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten Expired - Fee Related DE69509544T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions
PCT/US1995/001479 WO1995020972A1 (en) 1994-02-04 1995-02-02 Treatment of ovarian estrogen dependent conditions

Publications (2)

Publication Number Publication Date
DE69509544D1 true DE69509544D1 (de) 1999-06-10
DE69509544T2 DE69509544T2 (de) 1999-09-02

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69509544T Expired - Fee Related DE69509544T2 (de) 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Country Status (29)

Country Link
US (1) US5681817A (de)
EP (1) EP0785792B1 (de)
JP (1) JP3130048B2 (de)
KR (1) KR970700507A (de)
CN (1) CN1144486A (de)
AP (1) AP724A (de)
AT (1) ATE179610T1 (de)
AU (1) AU689229B2 (de)
BG (1) BG62238B1 (de)
BR (1) BR9506606A (de)
CA (1) CA2182183C (de)
CZ (1) CZ291709B6 (de)
DE (1) DE69509544T2 (de)
DK (1) DK0785792T3 (de)
ES (1) ES2132645T3 (de)
FI (1) FI963036A0 (de)
GR (1) GR3030164T3 (de)
HU (1) HUT74622A (de)
LT (1) LT4182B (de)
LV (1) LV11782B (de)
MD (1) MD1432C2 (de)
NZ (1) NZ281441A (de)
OA (1) OA10777A (de)
PL (1) PL178273B1 (de)
RO (1) RO117420B1 (de)
RU (1) RU2110274C1 (de)
SK (1) SK96296A3 (de)
TJ (1) TJ242B (de)
WO (1) WO1995020972A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218910B (hu) * 1994-07-22 2000-12-28 Ortho Pharmaceutical Corporation Gonadotrofin-felszabadító hormon antagonista-polipeptidek alkalmazása emlősben ivarmirigy-szteroid-függő állapotok gyógykezelésére szolgáló gyógyszerkészítmények előállítására
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6274573B1 (en) 1997-10-17 2001-08-14 Mochida Pharmaceutical Co., Ltd. Method of treatment for uterine leiomyoma
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
EP1229906B1 (de) * 1999-08-31 2007-10-10 Bayer Schering Pharma Aktiengesellschaft Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
CA2427731A1 (en) * 2000-10-30 2002-05-10 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
CA2597699C (en) * 2005-02-17 2012-07-31 Hadasit Medical Research Services And Development Ltd. Bisphosphonates for treating endometriosis
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
ES2814343T3 (es) * 2006-10-24 2021-03-26 Allergan Pharmaceuticals Int Ltd Composiciones y métodos para suprimir las proliferaciones endometriales
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
US20080287408A1 (en) * 2007-05-14 2008-11-20 Drugtech Corporation Endometriosis treatment
WO2009037704A1 (en) * 2007-09-20 2009-03-26 Bio-Pro Medical Ltd. Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
KR101585221B1 (ko) 2014-02-27 2016-01-13 권희완 지압대 겸용 지압 베개
EP3560555A1 (de) * 2018-04-26 2019-10-30 LifeArc Zusammensetzung zur behandlung einer oder mehrerer östrogenvermittelter krankheiten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE69126180T2 (de) 1990-03-16 1997-08-28 Applied Research Systems Behandlung polyzystischer ovarkrankheit
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
ES2132645T3 (es) 1999-08-16
DK0785792T3 (da) 1999-10-18
WO1995020972A1 (en) 1995-08-10
FI963036A (fi) 1996-08-01
RU2110274C1 (ru) 1998-05-10
JPH09508418A (ja) 1997-08-26
MD1432B2 (en) 2000-03-31
PL315792A1 (en) 1996-12-09
LT96133A (en) 1997-01-27
LT4182B (en) 1997-06-25
KR970700507A (ko) 1997-02-12
HU9601969D0 (en) 1996-09-30
AU1838695A (en) 1995-08-21
AU689229B2 (en) 1998-03-26
FI963036A0 (fi) 1996-08-01
CA2182183A1 (en) 1995-08-10
NZ281441A (en) 1999-09-29
OA10777A (en) 2002-12-23
BR9506606A (pt) 1997-09-09
AP724A (en) 1999-01-18
EP0785792B1 (de) 1999-05-06
EP0785792A1 (de) 1997-07-30
LV11782A (lv) 1997-06-20
SK96296A3 (en) 1997-07-09
HUT74622A (en) 1997-01-28
US5681817A (en) 1997-10-28
AP9600840A0 (en) 1996-07-31
GR3030164T3 (en) 1999-08-31
RO117420B1 (ro) 2002-03-29
MD1432C2 (ro) 2000-09-30
BG62238B1 (bg) 1999-06-30
DE69509544T2 (de) 1999-09-02
TJ242B (en) 1999-11-24
CA2182183C (en) 2003-09-16
EP0785792A4 (de) 1997-07-30
LV11782B (en) 1997-12-20
CZ210396A3 (en) 1997-05-14
BG100766A (en) 1997-06-30
CN1144486A (zh) 1997-03-05
PL178273B1 (pl) 2000-03-31
ATE179610T1 (de) 1999-05-15
JP3130048B2 (ja) 2001-01-31
CZ291709B6 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE246500T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE273954T1 (de) Verbindungen zur anwendung bei der behandlung entzündlicher erkrankungen
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE195527T1 (de) Neue steroidester zur behandlung von hauterkrankungen
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATE262331T1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
EE9900036A (et) Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee